Table 1.
Demographic characteristics and laboratory findings on admission.
| Variable | Survivors (n = 298) |
Non-survivors (n = 79) |
p value |
|---|---|---|---|
| Age, mean (range), years | 41.8 (±22.7) | 46.72 (±25.7) | 0.016 |
| Male, n (%) | 215 (72.1%) | 62 (78.5%) | 0.257 |
| Diabetes Mellitus, n (%) | 64 (21.5%) | 24 (30.4%) | 0.096 |
| Hypertension, n (%) | 56 (18.8%) | 20 (25.3%) | 0.199 |
| Cardiovascular disease, n (%) | 6 (2%) | 9 (11.4%) | 0.000 |
| COPD, n (%) | 8 (2.7%) | 8 (10.1%) | 0.013 |
| Dialysis, n (%) | 10 (3.4%) | 8 (10.1%) | 0.012 |
| Haemoglobin g/dl, median (IQR) | 14.8 (13.3−15.8) | 14 (12.2−15.5) | 0.022 |
| Leukocytes x103/µL, median (IQR) | 7.3 (5.4−10.8) | 9.4 (8.2−13.1) | 0.000 |
| Platelets x103/µL, median (IQR) | 219 (171.7−301.5) | 243 (180−310) | 0.454 |
| Creatinine mg/dl, median (IQR) | 0.86 (0.7−1) | 0.95 (0.7−1.7) | 0.005 |
| Total bilirubin mg/dl, median (IQR) | 0.77 (0.51−1) | 0.97 (0.6−2.2) | 0.000 |
| Alkaline phosphatase U/l, median (IQR) | 76 (58−102.5) | 102 (68−124) | 0.001 |
| ALT U/l, median (IQR) | 36 (26−56) | 46 (24−100) | 0.040 |
| AST U/l, median (IQR) | 43.5 (31−61.5) | 51 (36−142) | 0.000 |
| CRP mg/dl, median (IQR) | 121 (48−197) | 232 (126.5−321.5) | 0.000 |
| INR, median (IQR) | 1 (1−1.2) | 1 (1−1.2) | 0.888 |
| Albumin g/dl, median (IQR) | 3.5 (3−3.9) | 3.3 (3−3.7) | 0.283 |
| Sodium mmol/l, median (IQR) | 138 (136−140) | 137 (135−140) | 0.421 |
| LDH U/l, median (IQR) | 380.5 (265.7−523.2) | 536 (419−776) | 0.000 |
| MELD score, median (IQR) | 8 (6−10) | 9 (8−16) | 0.000 |
COPD (Chronic Obstructive Pulmonary Disease), ALT (alanine aminotransferase), AST (aspartate aminotransferase), CRP (C reactive protein), INR (international normalized ratio), LDH (lactate dehydrogenase), MELD (Model of End-Stage Liver Disease).